RFP
CRL icon

Root Financial Partners’s Charles River Laboratories CRL Stock Holding History

Root Financial Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-130
Closed -$22.4K – 1021
2026
Q1 		$22.4K Sell
130
-30
-19% -$5.56K ﹤0.01% 1252
2025
Q4 		$31.9K Buy
160
+47
+42% +$8.53K ﹤0.01% 912
2025
Q3 		$17.7K Buy
+113
New +$17.9K ﹤0.01% 1180

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Root Financial Partners's CRL Position: Q2 2026 in Review

Root Financial Partners sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 130 shares — an estimated $22.4K sold.

Root Financial Partners first reported a position in CRL in Q3 2025 and held it in 3 quarters. The position peaked at $31.9K in Q4 2025. 150 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Root Financial Partners reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 130 Charles River Laboratories shares in Q2 2026, an estimated $22.4K.
  • Root Financial Partners first reported a position in Charles River Laboratories in Q3 2025 and held it in 3 quarters.
  • Root Financial Partners's Charles River Laboratories position peaked at $31.9K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.